Clinical Trials Browser

Phase 1 × NETWORK × Gynecologic Cancer × Clear all

NCT02459301 2023-08-04

A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies

Phase 1 Completed

Gynecologic Cancer